Public health authorities are launching a nationwide effort to curb the seasonal rise in respiratory illnesses, announcing that the vacunación contra influenza 2026 will officially begin on Monday, April 13. The campaign, coordinated by the Programa Ampliado de Inmunizaciones (PAI), aims to provide widespread immunity before the peak circulation of respiratory viruses occurs.
The rollout is designed as a phased deployment to ensure that doses reach the most remote areas of the country without compromising the cold chain. Initial administration will start at major hospitals, which serve as the primary hubs for the first wave of vaccinations. Simultaneously, health officials are executing a “micro-distribution” strategy to move vaccines from these central hubs to local Unidades de Salud de la Familia (USF) and other community clinics.
This strategic distribution ensures that by the end of the first week, the entire network of health establishments will have available stock, allowing citizens to access the vaccine closer to their homes. The timing is critical, as the goal is to build population-level immunity ahead of the months when respiratory infections typically surge, putting pressure on the national healthcare system.
Who is eligible for the 2026 influenza vaccine?
The 2026 campaign prioritizes a broad range of the population, though the availability of specific doses varies by age group. From the start of the campaign on April 13, vaccines will be available for anyone aged 3 years and older. This wide window of eligibility is intended to reduce the overall viral load within the community, protecting not just the individual but also those who cannot be vaccinated for medical reasons.
For older adults, the health ministry is deploying a specialized tool. Individuals aged 50 and older will have access to an adjuvanted influenza vaccine. In medical terms, an adjuvant is an ingredient added to a vaccine that helps create a stronger immune response. Due to the fact that the immune system naturally weakens with age—a process known as immunosenescence—this enhanced version provides a more robust layer of protection for the elderly.
There is a slightly different timeline for the youngest patients. Doses specifically designated for children and infants between 6 and 35 months of age will not be available on day one. Instead, these will be integrated into the health network starting in the second half of April. The Ministry of Health has stated it will issue a separate communication once these specific pediatric doses are available at vaccination centers.
Co-administration with the Pneumococcal Vaccine
Beyond the flu shot, the PAI is utilizing this window to strengthen protection against pneumococcal disease. This is particularly vital for those aged 60 and older, especially those who have never been vaccinated against the pneumococcus bacterium or those whose last dose was administered more than five years ago.
From a clinical perspective, one of the most efficient aspects of this campaign is the ability to co-administer these shots. Health providers can administer the influenza vaccine and the pneumococcal vaccine during the same visit, typically in different arms. This reduces the number of trips a patient must make to a clinic, which is a significant factor in increasing vaccination rates among the elderly and those with limited mobility.
| Group | Vaccine Available | Availability Date | Special Note |
|---|---|---|---|
| Ages 3 to 49 | Standard Influenza | April 13 | Free of charge |
| Ages 50+ | Adjuvanted Influenza | April 13 | Enhanced immune response |
| Ages 6 to 35 months | Pediatric Influenza | Late April | Awaiting distribution |
| Ages 60+ | Pneumococcal | April 13 | If no dose in last 5 years |
Accessing services and removing barriers
To maximize turnout, the Ministry of Public Health and Social Welfare has removed common administrative hurdles. All vaccines provided through the PAI are free of charge. No medical order or prescription is required to receive the dose; citizens can simply walk into an authorized health center and request the vaccine.
Because the distribution moves from large hospitals to smaller USF clinics throughout the week, patients are encouraged to verify the current availability of vaccines at their nearest location. The government has centralized this information through a digital portal to prevent unnecessary travel to clinics that may still be awaiting their micro-distribution shipment.
To find an active vaccination point, citizens should visit the official portal at www.vacunate.gov.py. This tool allows users to see which services currently have the 2026 doses in stock.
Why this timing matters
The decision to start the campaign in mid-April is not arbitrary. Respiratory viruses typically follow a seasonal pattern, and the goal of the PAI is to ensure that the population has reached peak antibody levels before the virus reaches its highest circulation rate. When a large percentage of the population is vaccinated, it creates a “shield” effect that protects the most vulnerable, including those with chronic heart or lung conditions who are at higher risk for complications from the flu.
Disclaimer: This article is for informational purposes only and does not constitute individual medical advice. Please consult a healthcare provider for personalized medical guidance.
The next major milestone for the campaign will be the official announcement regarding the availability of doses for infants aged 6 to 35 months, expected in the latter half of April. Health officials will continue to monitor the distribution progress across the USF network to ensure total national coverage.
Do you have questions about the 2026 vaccination schedule? Share this article with your community or leave a comment below to let us recognize which health topics you want us to cover next.
